Prudential Financial
SCMP

Prudential Financial’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Prudential Financial’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-456,379
Closed -$8.19M – 2414
2017
Q4 		$8.19M Buy
456,379
+46,056
+11% +$567K 0.01% 973
2017
Q3 		$4.84M Buy
410,323
+368,090
+872% +$4.13M 0.01% 1164
2017
Q2 		$443K Sell
42,233
-19,900
-32% -$203K ﹤0.01% 2054
2017
Q1 		$683K Sell
62,133
-200,613
-76% -$2.33M ﹤0.01% 1963
2016
Q4 		$3.56M Sell
262,746
-70,807
-21% -$988K 0.01% 1262
2016
Q3 		$4.11M Sell
333,553
-100,100
-23% -$1.18M 0.01% 1170
2016
Q2 		$4.76M Sell
433,653
-16,900
-4% -$189K 0.01% 1140
2016
Q1 		$4.92M Sell
450,553
-286,500
-39% -$3.62M 0.01% 1106
2015
Q4 		$12.7M Buy
737,053
+304,100
+70% +$5.45M 0.02% 702
2015
Q3 		$8.6M Buy
432,953
+215,000
+99% +$4.93M 0.02% 803
2015
Q2 		$3.58M Buy
217,953
+118,200
+118% +$2.05M 0.01% 1266
2015
Q1 		$1.55M Sell
99,753
-5,300
-5% -$82.2K ﹤0.01% 1699
2014
Q4 		$1.5M Buy
+105,053
New +$1.11M ﹤0.01% 1593

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Prudential Financial's SCMP Position: Q1 2018 in Review

Prudential Financial sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 456,379 shares — an estimated $8.19M sold.

Prudential Financial first reported a position in SCMP in Q4 2014 and held it in 13 quarters. The position peaked at $12.7M in Q4 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Prudential Financial reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Prudential Financial sold 456,379 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $8.19M.
  • Prudential Financial first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
  • Prudential Financial's Sucampo Pharmaceuticals, Inc. position peaked at $12.7M in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Prudential Financial's 13F filing for Q1 2018, filed 4 May 2018.